BioSpace News Archive

CryoLife, Inc. announced today that it will participate in the upcoming Deutsche Bank 26th Annual Leveraged Finance Conference on Tuesday, October 2, 2018 at The Phoenician in Scottsdale, AZ.

Healthline and MedicalNewsToday Posted More than Two Times Growth Year-over-Year

Global patient recruitment and retention company, Continuum Clinical is proud to announce Kevin Hartbarger as its new vice president of media.

Today, the U.S. Food and Drug Administration took new steps as part of its broader efforts to address the opioid crisis by approving the final Opioid Analgesic Risk Evaluation and Mitigation Strategy (REMS).

Astellas today announced that Geoff Towle has been promoted to vice president, Oncology Marketing, Astellas US.

Innovative CT Technology Enables the Hospital to Expand Services to More Patients and Increase Exam Volume

Concept Life Sciences (Concept), the integrated drug discovery, development and analytical services company, today announced it has made three senior appointments to its Analytical Services Division.

The Janssen Pharmaceutical Companies of Johnson & Johnson announced today that a New Drug Application (NDA) has been submitted to the U.S. Food and Drug Administration (FDA) seeking approval of erdafitinib for the treatment of patients with locally advanced or metastatic urothelial cancer (UC) and certain fibroblast growth factor receptor (FGFR) genetic alterations whose tumors have progressed after prior chemotherapy.

Iterum Therapeutics plc (Nasdaq: ITRM), a clinical-stage pharmaceutical company developing antibiotics against multi-drug resistant pathogens, today announced its initiation of the second and third of three planned Phase 3 clinical trials for sulopenem, Iterum’s lead compound and novel antibiotic for the treatment of gram-negative, multi-drug resistant infections.

CloudLIMS is hosting a live webinar on September 25, 2018, on Biospecimen Quality for Precision Medicine.